CN109420525B - Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst - Google Patents

Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst Download PDF

Info

Publication number
CN109420525B
CN109420525B CN201710716094.6A CN201710716094A CN109420525B CN 109420525 B CN109420525 B CN 109420525B CN 201710716094 A CN201710716094 A CN 201710716094A CN 109420525 B CN109420525 B CN 109420525B
Authority
CN
China
Prior art keywords
reaction
arh
cdcl
methanol
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710716094.6A
Other languages
Chinese (zh)
Other versions
CN109420525A (en
Inventor
李峰
梁然
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Science and Technology
Original Assignee
Nanjing University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Science and Technology filed Critical Nanjing University of Science and Technology
Priority to CN201710716094.6A priority Critical patent/CN109420525B/en
Publication of CN109420525A publication Critical patent/CN109420525A/en
Application granted granted Critical
Publication of CN109420525B publication Critical patent/CN109420525B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2282Unsaturated compounds used as ligands
    • B01J31/2295Cyclic compounds, e.g. cyclopentadienyls
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B01J31/181Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
    • B01J31/1815Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/18Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to carbon atoms of six-membered aromatic rings or from amines having nitrogen atoms bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4277C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues
    • B01J2231/4283C-X Cross-coupling, e.g. nucleophilic aromatic amination, alkoxylation or analogues using N nucleophiles, e.g. Buchwald-Hartwig amination
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0225Complexes comprising pentahapto-cyclopentadienyl analogues
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/827Iridium

Abstract

The invention discloses a metal iridium catalyst of a 2, 2' -bisbenzimidazole ligand and a method for synthesizing N-methylated primary amine by using the metal iridium complex containing the bisimidazole ligand as a catalyst activation source, wherein the methylation reaction is carried out on methanol with wide source and low toxicity and aromatic primary amine. Compared with the prior art, only weak base needs to be added in the reaction process, the reaction temperature is 120 ℃, nitrogen protection is not needed, and harsh conditions such as high temperature, high pressure, long-time reaction and the like are needed; meanwhile, the byproduct is only generated by water, and the environment pollution is avoided, so the method has wide development prospect.

Description

Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst
Technical Field
The invention belongs to the technical field of metal organic chemistry and organic synthetic chemistry, and particularly relates to a metal iridium catalyst and a synthetic method of N-methylated primary amine thereof.
Background
N-methylated primary amine reaction is an important organic synthesis reaction and is widely applied to synthesis of natural products, fine chemicals, pharmaceuticals and key intermediates. (a) Carey, f.a.; sundberg, r.j.advanced Organic Chemistry,4th ed.; kluwer Academic: New York, 2001; part B, Chapter 3.2.5.B) Aurelio, l.; brownlee, r.t.c.; hughes, A.B.chem.Rev.2004,104, 5823-5846.). For example, paliperidone hydrochloride has a remarkable inhibitory effect on platelet-derived growth factor receptors and vascular endothelial growth factor receptors, and has an inhibitory effect on multiple tumors such as non-small cell lung cancer, renal cell carcinoma, sarcoma and the like.
The main synthesis method of N-methylated primary amine is that the conventional method is that halogenated methane or dimethyl sulfate is used as a methylating agent to perform nucleophilic substitution reaction with amine. The method uses highly toxic raw materials, a large amount of alkali, generates halogen acid salt as a byproduct to pollute the environment, generates disubstituted methylation products at the same time, has low selectivity, and also causes low atomic efficiency of the reaction (a) F.A.Carey, R.J.Sundberg, Advanced Organic Chemistry,4th ed.; kluwer Academic: New York, 2001; part B, Chapter 3.2.5; b) R.N.Salvator, C.H.Yoon, K.W.Jung, Tetrahedron 2001,57, 7785-.
In recent years, the activation of methanol as a methylating agent by using a metal catalyst of ruthenium, iridium, manganese or the like has attracted much attention. (a) T.t.dang, b.ramalingam, m.a.seayad, ACS catal.2015,5,4082-4088.b) f.li, j.j.xie, h.shan, c.sun, l.chen, RSC adv.2012,2, 8645-; b) s.michlik, t.hill, r.kempe, adv.synth.catal.2012,354, 847-862; c) j.campos, l.s.sharninghausen, g.m.manas, r.h.crabtree, inorg.chem.2015,54,5079-5084.d) s.elangovan, j.neumann, j.b.sortais, k.junge, c.darcel, m.beller, nat.commu.2016, 7, 12641-: firstly, dehydrogenating methanol under the action of a transition metal catalyst to generate aldehyde and a transition metal hydrogen complex; then, formaldehyde and nucleophilic reagent amine compound are subjected to condensation reaction to generate condensation product and water; finally, the condensation product is subjected to reductive hydrogenation to generate an N-methylation product, and simultaneously, the transition metal hydrogen complex is dehydrogenated to complete the catalyst circulation. The methanol with wide sources and low toxicity is used as a methylating agent, only water is generated as a byproduct in the reaction, the method is environment-friendly, and the reaction atom economy is high. However, the catalytic synthesis needs high temperature (150 ℃), long reaction time (48h), a large amount of strong base, nitrogen protection and other harsh conditions. From the aspects of synthesis and environment, the development of a novel metal catalyst is urgently needed to realize that the reaction condition of N-methylated primary amine is milder and the environment is more friendly.
Disclosure of Invention
The invention aims to provide a metallic iridium catalyst and a synthetic method of N-methylated primary amine thereof.
The invention is realized by the following technical scheme:
the metallic iridium catalyst (formula I) of the 2, 2' -bis-benzimidazole ligand has the following structure:
Figure BDA0001383796820000021
a method for synthesizing the above catalyst, which comprises reacting dichloro (pentamethylcyclopentadienyl) iridium dimer (formula II)
[Cp*IrCl2]2
II
Is subjected to metal complex reaction with benzo-bisimidazole (formula III)
Figure BDA0001383796820000022
The reaction formula is
Figure BDA0001383796820000023
The specific synthesis steps are as follows: adding dichloro (pentamethylcyclopentadienyl) iridium dimer II, bis-benzimidazole III and solvent N, N-dimethylformamide into a reaction vessel, heating for several hours under the protection of nitrogen, cooling to room temperature, and filtering to obtain the target product.
Wherein, the dosage of the bisbenzimidazole is 2.2 equivalents of dichloro (pentamethylcyclopentadienyl) iridium dimer; the reaction temperature is 60 +/-10 ℃; the reaction time is not less than 12 hours.
Method for the synthesis of N-methylated primary amines (formula IV):
Figure BDA0001383796820000031
which comprises reacting an amine (formula V)
Figure BDA0001383796820000032
Methylation reaction with methanol (formula VI)
MeOH
VI
The reaction is carried out in the presence of a metal iridium catalyst of a 2, 2' -bis-benzimidazole ligand and a base, and the general formula of the reaction is
Figure BDA0001383796820000033
Wherein R is1Selected from the group consisting of methylphenyl, methoxyphenyl, trifluoromethylphenyl, halophenyl, pyridyl, pyrazinyl, benzimidazolyl, benzothiazolyl, benzoxazolyl, methylphenylsulfonyl, methoxyphenylsulfonyl, trifluoromethylphenylsulfonyl, halophenylsulfonyl.
The specific synthesis steps are as follows: adding amine, methanol, a metal iridium catalyst of a 2, 2' -bisbenzimidazole ligand and alkali into a reaction vessel, reacting the reaction mixture in an oil bath for several hours, cooling to room temperature, removing the solvent by rotary evaporation, and separating by a column to obtain the target compound.
Further, the base is selected from cesium carbonate; the molar ratio of the catalyst to the amine was 1.0 mol%; the molar ratio of base to amine is 0.3-0.5 equivalents; the reaction is carried out at 120 plus or minus 10 ℃; the reaction time is more than 12 hours.
Compared with the prior art, the iridium complex catalyst with the bisimidazole ligand is used for activating the methylation reaction of methanol with wide sources and low toxicity and amine, only 0.3-0.5 equivalent of weak base needs to be added in the reaction process, the reaction temperature is 120 +/-10 ℃, the reaction time is only over 12 hours, the reaction condition is milder, only water is generated as a byproduct, no environmental hazard is caused, and the reaction atom economy is high. Therefore, the reaction meets the requirement of green chemistry and has wide development prospect.
Detailed Description
The following examples are shown to illustrate certain embodiments of the present invention and should not be construed as limiting the scope of the invention. Many modifications, variations and changes in materials, methods and reaction conditions may be made simultaneously with respect to the disclosure herein. All such modifications, variations and changes are intended to fall within the spirit and scope of the present invention.
Example 1:
[Cp*Ir(BiBzImH2)Cl][Cl]
Figure BDA0001383796820000041
dichloro (pentamethylcyclopentadienyl) iridium dimer (100mg,0.126mmol), bisbenzimidazole (65mg,0.277mmol,2.2equiv), and N, N-dimethylformamide (3mL) were added in that order to a 25mL k tube. Reacting at 60 ℃ for 12 hours under the protection of nitrogen, and cooling to room temperature. Filtration and washing with petroleum ether gave the desired product as a yellow solid. Yield: 65 percent of
1H NMR(500MHz,CDCl3)δ14.9(br s,2H),7.78(d,J=8.4Hz,2H),7.70(d,J=8.4Hz,2H),7.50(t,J=7.2Hz,2H),7.45(t,J=7.2Hz,2H),1.84(s,15H);13C NMR(125MHz,CDCl3)δ144.1,138.9,134.2,126.2,125.1,116.5,115.0,87.6,10.2.HRMS-EI(70eV)m/z calcd for C24H25ClIrN4[M+H]+597.1392,found 597.1397.。
The single crystal structure is as follows:
Figure BDA0001383796820000051
single crystal structure: bond length (10)-10m), bond angle (degrees): Ir-N1,2.145 (11); Ir-N3,2.117 (13); Ir-C5 (Cp), 2.159 (16); Ir-Cl,2.400 (5); N1-Ir-N3,75.9 (5); N1-Ir-Cl1,86.5 (3); N3-Ir-Cl1,89.0(4).
Example 2:
n-methylaniline
N-methylbenzenamine
Figure BDA0001383796820000052
Aniline (46mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 92 percent of
1HNMR(500MHz,CDCl3)δ7.19(t,J=7.7Hz,2H,ArH)),6.7(t,J=7.4Hz,1H,ArH),6.6(d,J=8.1Hz,2H,ArH),2.8(s,2H,CH3);13C NMR(125MHz,CDCl3)δ149.2,129.1,117.1,112.3,30.6.。
Example 3:
4-chloro-N-methylaniline
4-chloro-N-methylbenzenamine
Figure BDA0001383796820000061
P-chloroaniline (71mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 90 percent of
1HNMR(500MHz,CDCl3)δ7.11(d,J=8.8Hz,2H,ArH),6.51(d,J=8.8Hz,2H,ArH),3.69(br s,1H,NH),2.79(s,3H,CH3);13C NMR(125MHz,CDCl3)δ147.8,128.8,121.5,113.5,30.6.。
Example 4:
3-chloro-N-methylaniline
3-chloro-N-methylbenzenamine
Figure BDA0001383796820000062
3-chloroaniline (71mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Km tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 89 percent
1H NMR(500MHz,CDCl3)δ7.06(t,J=8.1Hz,1H,ArH),6.64(d,J=2.1Hz,1H,ArH),6.54(t,J=8.1Hz,1H,ArH),6.43(dd,J=8.4Hz and 2.2Hz,1H,ArH),2.78(s,3H,CH3);13C NMR(125MHz,CDCl3)δ150.4,134.9,130.0,116.9,111.8,110.7,30.4.。
Example 5:
4-fluoro-N-methylaniline
4-fluoro-N-methylbenzenamine
Figure BDA0001383796820000071
Para-fluoroaniline (54mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL k-tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 93 percent
1HNMR(500MHz,CDCl3)δ6.89(t,J=9.1Hz,2H,ArH),6.51(m,2H,ArH),2.8(s,3H,CH3);13C NMR(125MHz,CDCl3)δ156.6,154.8,148.6,115.6,130.0,31.2.。
Example 6:
2-fluoro-N-methylaniline
2-fluoro-N-methylbenzenamine
Figure BDA0001383796820000072
2-fluoroaniline (54mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 87 percent of
1H NMR(500MHz,CDCl3)δ7.01(t,J=8.0Hz,1H,ArH),6.95(dd,J=3.9Hz and 8.0Hz,1H,ArH),6.68(t,J=8.0Hz,1H,ArH),6.59-6.63(m,1H,ArH),3.93(br s,1H,NH),2.87(s,3H,CH3);13C NMR(125MHz,CDCl3)δ152.4,150.6,145.7(d,JC-F=11.9Hz),124.5(d,JC-F=3.9Hz),116.2(d,JC-F=6.6Hz),114.0(d,JC-F=18.3Hz),113.4(d,JC-F=2.8Hz),31.3.。
Example 7:
3, 5-difluoro-N-methylaniline
3,5-difluoro-N-methylbenzenamine
Figure BDA0001383796820000081
3, 5-difluoroaniline (64mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 94 percent of
1HNMR(500MHz,CDCl3)δ6.13-6.09(m,1H,ArH),6.07-6.05(m,2H,ArH),3.92(br s,1H,NH),2.79(d,J=5.2Hz,3H,CH3);13C NMR(125MHz,CDCl3)δ164.2,151.5,90.0-94.8,92.0,30.4。
Example 8:
4-bromo-N-methylaniline
4-bromo-N-methylbenzenamine
Figure BDA0001383796820000082
Para-bromoaniline (97mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 83 percent
1HNMR(500MHz,CDCl3)δ7.15(d,J=8.9Hz,2H,ArH),6.34(d,J=8.8Hz,2H,ArH),2.67(s,3H,CH3);13C NMR(125MHz,CDCl3)δ148.1,131.7,113.8,108.6,30.5.。
Example 9:
4-trifluoromethoxy-N-methylaniline
N-methyl-4-(trifluoromethoxy)benzenamine
Figure BDA0001383796820000091
P-trifluoromethoxyaniline (95mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 92 percent of
1H NMR(500MHz,CDCl3)δ7.03(d,J=8.7Hz,2H,ArH),6.51(d,J=8.8Hz,2H,ArH),2.82(s,3H,CH3);13C NMR(125MHz,CDCl3)δ148.1,140.3,122.3,119.7(q,JC-F=255.6Hz),112.5,30.8.。
Example 10:
n, 4-methanesulfonyl aniline
N-methyl-4-(methylsulfonyl)benzenamine
Figure BDA0001383796820000092
4-Methanesulfonylaniline (86mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 95 percent
1HNMR(500MHz,CDCl3)δ7.69(d,J=8.8Hz,2H,ArH),6.6(d,J=9Hz,2H,ArH),4.39(br s,1H,NH),3.00(s,3H,CH3),2.89(d,J=5.2Hz,3H,CH3);13C NMR(125MHz,CDCl3)δ153.1,129.2,126.9,111.3,45.0,30.0.。
Example 11:
n-methyl-4-cyanoaniline
4-(methylamino)benzonitrile
Figure BDA0001383796820000101
4-cyanoaniline (59mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (82mg,0.25mmol,0.5equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 82 percent of
1H NMR(500MHz,CDCl3)δ7.41(d,J=8.7Hz,2H,ArH),6.54(d,J=8.7Hz,2H,ArH),4.42(br s,1H,NH),2.86(d,J=4.9Hz,3H,CH3);13C NMR(125MHz,CDCl3)δ152.2,133.5,120.6,117.7,98.0,29.8.。
Example 12:
4-acetyl-N-methylaniline
1-(4-(methylamino)phenyl)ethanone
Figure BDA0001383796820000111
4-Aminoacetophenone (68mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 92 percent of
1H NMR(500MHz,CDCl3)δ7.83(d,J=8.8Hz,2H,ArH),6.55(d,J=8.8Hz,2H,ArH),4.31(br s,1H,NH),2.89(d,J=5.3Hz,3H,CH3),2.50(s,3H);13C NMR(125MHz,CDCl3)δ196.4,153.1,130.7,126.5,110.9,30.1,26.0.。
Example 13:
4-methylaminobenzoic acid methyl ester
methyl 4-(methylamino)benzoate
Figure BDA0001383796820000112
Methyl p-aminobenzoate (76mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 78 percent of
1H NMR(500MHz,CDCl3)δ7.86(d,J=8.8Hz,2H,ArH),6.53(d,J=8.8Hz,2H,ArH),4.27(br s,1H,NH),3.84(s,3H,3H),2.86(s,3H);13C NMR(125MHz,CDCl3)δ167.4,152.9,131.4,118.0,111.0,51.4,30.0.。
Example 14:
n, 4-dimethylaniline
N,4-dimethylbenzenamine
Figure BDA0001383796820000121
P-methylaniline (61mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (82mg,0.25mmol,0.5equiv.), and methanol (1mL) were added to a 25mL Kjeldahl tube in that order. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 85 percent of
1HNMR(500MHz,CDCl3)δ6.99(d,J=8.2Hz,2H,ArH),6.54(d,J=8.3Hz,2H,ArH),2.80(s,3H,CH3),2.23(s,3H,CH3);13C NMR(125MHz,CDCl3)δ147.1,129.6,126.4,31.0,20.3.。
Example 15:
3-methoxy-N-methylaniline
3-methoxy-N-methylbenzenamine
Figure BDA0001383796820000122
M-methoxyaniline (69mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (82mg,0.25mmol,0.5equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 91 percent
1HNMR(500MHz,CDCl3)δ7.08(t,J=8.1Hz,1H,ArH),6.27(dd,J=8.8Hz and 2.2Hz,1H,ArH),6.26(dd,J=8.3Hz and 1.9Hz,1H,ArH),3.77(s,3H,CH3),2.8(s,3H,CH3);13C NMR(125MHz,CDCl3)δ160.8,150.7,129.8,105.6,102.3,98.3,55.0,30.6.。
Example 16:
3-chloro-N, 4-dimethylaniline
3-chloro-N,4-dimethylbenzenamine
Figure BDA0001383796820000131
3-chloro-p-toluidine (70.8mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 94 percent of
1HNMR(500MHz,CDCl3)δ7.41(d,J=2.2Hz,1H,ArH),7.09(d,J=1.9Hz,1H,ArH),5.69(br s,1H,NH),3.07(s,3H,CH3),2.51(s,3H,CH3);13C NMR(125MHz,CDCl3)δ148.4,134.7,123.9,112.4,111.2,30.7,18.8.。
Example 17:
n-methyl-2-naphthylamine
N-methylnaphthalen-2-amine
Figure BDA0001383796820000132
2-naphthylamine (72mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 84 percent
1HNMR(500MHz,CDCl3)δ7.78(m,2H,ArH),7.44(m,2H,ArH),7.37(t,J=8Hz,1H,ArH),7.24(s,1H,ArH),4.43(br s,1H,NH),3.07(s,3H,CH3),3.02(s,3H,CH3);13C NMR(125MHz,CDCl3)δ147.0,135.3,128.8,127.6,127.5,126.3,125.9,121.9,117.9,103.7,30.6.。
Example 18:
n, 5-dimethylpyridin-2-amine
N,5-dimethylpyridin-2-amine
Figure BDA0001383796820000141
5-methyl-2-aminopyridine (61mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 90 percent of
1H NMR(500MHz,CDCl3)δ7.91(s,1H,ArH),7.23(m,1H,ArH),6.30(d,J=8.4Hz,1H,ArH),4.59(br s,1H,NH),2.87(s,3H,CH3),2.16(s,3H,CH3);13C NMR(125MHz,CDCl3)δ157.8,147.4,138.2,121.1,105.7,29.1,17.2.。
Example 19:
n-methylpyridin-2-amine
N-methylpyridin-2-amine
Figure BDA0001383796820000142
2-aminopyridine (54mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (82mg,0.25mmol,0.5equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 88 percent
1H NMR(500MHz,CDCl3)δ8.07(d,J=5.2Hz,1H,ArH),7.40(t,J=7.2Hz,1H,ArH),6.55(d,J=6.1Hz,1H,ArH),6.35(dd,J=1.1and 8.4Hz,1H,ArH),4.86(br s,1H,ArH),2.89(s,3H,CH3);13C NMR(125MHz,CDCl3)δ159.5,147.9,137.2,112.4,106.0,28.8。
Example 20:
n-methylpyrazin-2-amine
Pyrazin-2-ylamine
Figure BDA0001383796820000151
Aminopyrazine (42mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 95 percent
1HNMR(500MHz,CDCl3)δ7.99(s,1H,ArH),7.89(s,1H,ArH),7.8(d,J=2.8Hz,1H,ArH),4.71(br s,1H,NH),2.97(d,J=5.2Hz,3H,CH3);13C NMR(125MHz,CDCl3)δ155.2,141.7,132.0,131.7,28.0.。
Example 21:
6-chloro-N-4-methylbenzothiazol-2-amine
6-chloro-N,4-dimethylbenzo[d]thiazol-2-amine
Figure BDA0001383796820000152
6-chloro-4-methylaminobenzothiazole (99mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added to a 25mL gram-vial in that order. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 92 percent of
1HNMR(500MHz,CDCl3)δ7.41(d,J=2.1Hz,1H,ArH),7.09(s,1H,ArH),7.37(t,J=8Hz,1H,ArH),5.69(br s,1H,NH),3.07(s,3H,CH3),2.5(s,3H,CH3);13C NMR(125MHz,CDCl3)δ168.1,150.2,131.0,129.5,127.0,126.0,117.9,31.9,18.2.。
Example 22:
n-methyl-1-benzylbenzothiazol-2-amines
1-benzyl-N-methyl-1H-benzo[d]imidazol-2-amine
Figure BDA0001383796820000161
2-amino-1-benzylbenzothiazole (112mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added to a 25mL krusel tube in that order. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 94 percent of
1HNMR(500MHz,CDCl3)δ7.53(d,J=7.8Hz,1H,ArH),7.35-7.28(m,3H,ArH),7.15-7.13(m,3H,ArH),7.07-7.03(m,2H,ArH),5.08(s,2H,CH2),4.01(br s,1H,NH),3.07(d,J=5.13Hz,3H,CH3);13C NMR(125MHz,CDCl3)δ155.1,142.2,135.4,134.9,129.1,128.0,126.3,121.4,119.7,107.3,45.5,30.0.。
Example 23:
n-methylbenzenesulfonamides
N-methylbenzenesulfonamide
Figure BDA0001383796820000162
Benzenesulfonamide (79mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 95 percent
1HNMR(500MHz,CDCl3)δ7.86(d,J=7.8Hz,2H,ArH),7.59(t,J=7.4Hz,1H,ArH),7.53(t,J=7.6Hz,2H,ArH),3.41(br s,1H,NH),2.66(s,3H,CH3);13C NMR(125MHz,CDCl3)δ138.7,132.6,129.0,127.1,29.1.。
Example 24:
n, 4-dimethyl benzene sulfonamide
N,4-dimethylbenzenesulfonamide
Figure BDA0001383796820000171
P-toluenesulfonamide (86mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusette. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 94 percent of
1HNMR(500MHz,CDCl3)δ7.74(d,J=8.2Hz,2H,ArH),7.31(d,J=8.1Hz,2H,ArH),2.64(s,3H,CH3),2.43(s,3H,CH3);13C NMR(125MHz,CDCl3)δ143.4,135.7,129.6,127.2,29.2,21.4.。
Example 25:
n, 2-methylbenzenesulfonamides
N,2-dimethylbenzenesulfonamide
Figure BDA0001383796820000181
M-toluenesulfonamide (86mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusette. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 90 percent of
1HNMR(500MHz,CDCl3)δ7.96(d,J=8.1Hz,1H,ArH),7.46(t,J=7.3Hz,1H,ArH),7.33(t,J=6.4Hz,2H,ArH),2.64-2.63(m,6H,CH3);13C NMR(125MHz,CDCl3)δ137.0,136.7,132.7,132.5,129.6,126.0,28.9,20.2.。
Example 26:
3-chloro-N-methylbenzenesulfonamide
3-chloro-N-methylbenzenesulfonamide
Figure BDA0001383796820000182
M-chlorobenzenesulfonamide (96mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL K.tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 92 percent of
1HNMR(500MHz,CDCl3)δ7.86(s,1H,ArH),7.75(d,J=7.5Hz,1H,ArH),7.56(d,J=7.5Hz,1H,ArH),7.48(t,J=7.7Hz,1H,ArH),2.69(s,3H,CH3);13C NMR(125MHz,CDCl3)δ140.5,135.2,132.8,130.4,127.2,125.2,29.2.。
Example 27:
4-bromo-N-methylbenzenesulfonamides
4-Bromo-benzenesulfonamide
Figure BDA0001383796820000191
Para-bromobenzenesulfonamide (118mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 92 percent of
1HNMR(500MHz,CDCl3)δ7.7(d,J=8.9Hz,2H,ArH),7.6(d,J=8.9Hz,2H,ArH),2.67(s,3H,CH3);13C NMR(125MHz,CDCl3)δ137.8,132.8,128.7,127.6,29.2.。
Example 28:
n-methyl-4-trifluoromethylbenzenesulfonamide
N-methyl-4-(trifluoromethyl)benzenesulfonamide
Figure BDA0001383796820000192
P-trifluoromethylbenzenesulfonamide (113mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 93 percent
1HNMR(500MHz,CDCl3)δ8(d,J=8.2Hz,2H,ArH),7.7(d,J=8.3Hz,2H,ArH),2.69(s,3H,CH3);13C NMR(125MHz,CDCl3)δ142.5,134.5,127.7,123.6,123.2,29.2.。
Example 29:
n-methyl-4-trifluoromethoxybenzenesulphonamide
N-methyl-4-(trifluoromethoxy)benzenesulfonamide
Figure BDA0001383796820000201
P-trifluoromethoxybenzenesulfonamide (120mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL K.tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 96 percent
Yellow oil;96%yield(122.41mg);1H NMR(500MHz,CDCl3)δ7.90(d,J=8.8Hz,2H,ArH),7.31(d,J=8.7Hz,2H,ArH),4.01(br s,1H,NH),2.63(s,3H,CH3);13C NMR(125MHz,CDCl3)δ151.9,137.6,129.3,119.2(q,JC-F=260.1Hz),29.2.。
Example 30:
n-methyl-2-naphthalenesulfonamides
N-methylnaphthalene-2-sulfonamide
Figure BDA0001383796820000202
Naphthalene-2-benzenesulfonamide (96mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL Kjeldahl tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 93 percent
1H NMR(500MHz,CDCl3)δ8.44(s,1H,ArH),7.97(d,J=8.6Hz,2H,ArH),7.91(d,J=8.2Hz,1H,ArH),7.84(d,J=8.6Hz,1H,ArH),7.65(t,J=7.2Hz,1H,ArH),7.61(t,J=7.1Hz,1H,ArH),4.59(br s,1H,NH),2.69(d,J=5.4Hz,3H,CH3);13C NMR(125MHz,CDCl3)δ135.4,134.7,132.0,129.4,129.1,128.7,128.6,127.8,127.4,122.2,29.2.。
Example 31:
n-methylbenzenesulfonamide
N-methyl(phenyl)methanesulfonamide
Figure BDA0001383796820000211
Benethanamide (86mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusette tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 92 percent of
1HNMR(500MHz,CDCl3)δ7.37(s,5H,ArH),4.42(br s,1H,NH),4.41(s,2H,CH3),2.64(s,3H,CH3);13C NMR(125MHz,CDCl3)δ130.5,129.3,128.8,128.6,57.5,29.6.。
Example 32:
n-methylcyclopropanesulfonamide
Cyclopropanesulfonic acid amide
Figure BDA0001383796820000212
Cyclopropanesulfonamide (60mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 89 percent
1HNMR(500MHz,CDCl3)δ2.84(s,3H,CH3),2.44-2.44(m,1H),1.17(m,2H),1(m,2H);13C NMR(125MHz,CDCl3)δ29.3,28.4,4.8.。
Example 33:
n-methylmethanesulfonamide
N-methylmethanesulfonamide
Figure BDA0001383796820000221
Methylsulfonamide (48mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL krusel tube. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The solvent was removed by rotary evaporation and then purified by column chromatography (developing solvent: petroleum ether/ethyl acetate) to give the pure title compound in the following yields: 90 percent of
1H NMR(500MHz,CDCl3)δ2.95(s,3H,CH3),2.84(s,3H,CH3);13C NMR(125MHz,CDCl3)δ38.5,29.2.。
Comparative example 1:
aniline (46mg,0.5mmol), cat 2(4.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The nuclear magnetic yield was 93%.
Figure BDA0001383796820000222
Comparative example 2:
aniline (46mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (16mg,0.05mmol,0.1equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The nuclear magnetic yield was 81%.
Comparative example 3:
aniline (46mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), cesium carbonate (49mg,0.05mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 110 ℃ the reaction mixture was cooled to room temperature. The nuclear magnetic yield is 52%.
Comparative example 4:
aniline (46mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), potassium carbonate (21mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL gram-vial. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The nuclear magnetic yield is 84%.
Comparative example 5:
aniline (46mg,0.5mmol), cat 1(3.2mg,0.005mmol,1 mol%), sodium carbonate (16mg,0.15mmol,0.3equiv.), and methanol (1mL) were added sequentially to a 25mL kreb. After 12 hours of reaction at 120 ℃ the reaction mixture was cooled to room temperature. The nuclear magnetic yield is 79%.

Claims (9)

  1. A metal iridium catalyst I of a 2, 2' -bis-benzimidazole ligand is characterized by having the following structure:
    Figure FDA0003222079050000011
  2. 2. a process for preparing the iridium metal catalysts I as claimed in claim 1, comprising reacting dichloro (pentamethylcyclopentadienyl) iridium dimer II
    [Cp*IrCl2]2
    II
    A step of carrying out metal complex reaction with the benzimidazole III,
    Figure FDA0003222079050000012
  3. 3. the process according to claim 2, characterized in that the reaction is carried out in the presence of N, N-dimethylformamide as solvent.
  4. 4. The method according to claim 2, characterized in that the reaction is carried out under nitrogen protection; the amount of the bis-benzimidazole III is 2.2 equivalents of dichloro (pentamethylcyclopentadienyl) iridium dimer II; the reaction temperature is 60 +/-10 ℃; the reaction time is not less than 12 hours.
  5. 5. A process for the synthesis of N-methylated primary amines IV,
    Figure FDA0003222079050000013
    which comprises reacting an amine V
    Figure FDA0003222079050000014
    With methanol VI in the presence of a metal iridium catalyst I of a 2, 2' -bisbenzimidazole ligand and a base, with MeOH
    VI
    Figure FDA0003222079050000021
    Wherein R is1Comprises a compound selected from the group consisting of methylphenyl, methoxyphenyl, trifluoromethylphenyl, halophenyl, pyridyl, pyrazinyl, benzimidazolyl, benzothiazolyl, benzoxazolyl, methylphenylsulfonyl, methoxyphenylsulfonyl, trifluoromethylphenylsulfonyl, and halophenylsulfonyl.
  6. 6. The method of claim 5, wherein the base is selected from cesium carbonate.
  7. 7. The process according to claim 5, wherein the iridium metal catalyst of the 2, 2' -bibenzimidazole ligand is used in a molar ratio of 1.0 mol% with respect to the amine.
  8. 8. The process according to claim 5, characterized in that the molar ratio of base to amine is between 0.3 and 0.5 equivalents.
  9. 9. The process according to claim 5, wherein the reaction is carried out at 120 ± 10 ℃; the reaction time is more than 12 hours.
CN201710716094.6A 2017-08-21 2017-08-21 Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst Active CN109420525B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710716094.6A CN109420525B (en) 2017-08-21 2017-08-21 Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710716094.6A CN109420525B (en) 2017-08-21 2017-08-21 Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst

Publications (2)

Publication Number Publication Date
CN109420525A CN109420525A (en) 2019-03-05
CN109420525B true CN109420525B (en) 2021-10-08

Family

ID=65498795

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710716094.6A Active CN109420525B (en) 2017-08-21 2017-08-21 Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst

Country Status (1)

Country Link
CN (1) CN109420525B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110857278B (en) * 2018-08-23 2022-04-15 南京理工大学 Method for synthesizing N-methylsulfonamide in water
CN110372517A (en) * 2019-07-05 2019-10-25 大连理工大学 A method of amine N- methylation is catalyzed by utilization of carbon source complex of iridium of methanol
CN112409186B (en) * 2019-08-20 2022-12-13 南京理工大学 Method for synthesizing N-methylaniline in water
CN114213469B (en) * 2021-12-14 2023-03-17 武汉理工大学 Metal organic complex containing benzimidazole skeleton and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101503487A (en) * 2009-03-04 2009-08-12 中国石油天然气股份有限公司 Olefin polymerizing catalyst containing IVB metal, preparation and use thereof
CN103044337A (en) * 2011-10-13 2013-04-17 南京理工大学 Synthetic method of 2-(N-alkyl)aminooimidazole derivatives
CN103172523A (en) * 2011-12-23 2013-06-26 南京理工大学 Method for realizing selective N-methylation of primary amine
CN105218588A (en) * 2015-09-10 2016-01-06 南京邮电大学 A kind of preparation method and application of pyridyl benzoglyoxaline phenylquinoline iridium (III) title complex based on Long carbon chain modification
CN106146358A (en) * 2015-04-15 2016-11-23 南京理工大学 A kind of method of synthesizing amino-(N-alkyl) benzsulfamide
CN106518789A (en) * 2015-09-15 2017-03-22 南京理工大学 Method for synthesis of quinazolinone derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9212197B2 (en) * 2011-05-19 2015-12-15 Universal Display Corporation Phosphorescent heteroleptic phenylbenzimidazole dopants

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101503487A (en) * 2009-03-04 2009-08-12 中国石油天然气股份有限公司 Olefin polymerizing catalyst containing IVB metal, preparation and use thereof
CN103044337A (en) * 2011-10-13 2013-04-17 南京理工大学 Synthetic method of 2-(N-alkyl)aminooimidazole derivatives
CN103172523A (en) * 2011-12-23 2013-06-26 南京理工大学 Method for realizing selective N-methylation of primary amine
CN106146358A (en) * 2015-04-15 2016-11-23 南京理工大学 A kind of method of synthesizing amino-(N-alkyl) benzsulfamide
CN105218588A (en) * 2015-09-10 2016-01-06 南京邮电大学 A kind of preparation method and application of pyridyl benzoglyoxaline phenylquinoline iridium (III) title complex based on Long carbon chain modification
CN106518789A (en) * 2015-09-15 2017-03-22 南京理工大学 Method for synthesis of quinazolinone derivative

Also Published As

Publication number Publication date
CN109420525A (en) 2019-03-05

Similar Documents

Publication Publication Date Title
CN109420525B (en) Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst
Karpov et al. Straightforward novel one-pot enaminone and pyrimidine syntheses by coupling-addition-cyclocondensation sequences
Wang et al. Room temperature, open-flask C–H arylation of electron-deficient heteroarenes with triazenes: rapid synthesis of heterobiaryls
CN108017479B (en) Method for producing aromatic compound
CN103224436A (en) Preparation method of o-amino diaryl ketone compound
CN108690007B (en) C-H coupling reaction catalyzed by transition metal for efficiently preparing o-cyanoated aromatic ring or unsaturated aliphatic ring compound
Xu et al. Copper‐Chiral Camphor β‐Amino Alcohol Complex Catalyzed Asymmetric Henry Reaction
US20100041880A1 (en) Supramolecular Scaffolds and Methods of Making the Same
CN103980280A (en) Method for synthesizing quinazolino indazole derivatives under acidic condition
Hu et al. Synthesis of Alkyl-Substituted Pyridines by Directed Pd (II)-Catalyzed C–H Activation of Alkanoic Amides
JP6794041B2 (en) Method for producing aromatic amine
CN109422722A (en) A kind of preparation method of benzothienyl compounds intermediate
CN110981790B (en) 1,4-dihydropyridine derivative and synthetic method thereof
CN107628960B (en) Method for synthesizing ketene aminal by olefin in one step
CN102731386B (en) Preparation method of para-diimide derivative
CN110225753B (en) Process for preparing 5-phenoxy-1 (3H) isobenzofuranones
CN101863826A (en) Method for preparing 2-benzyl pyridine compound
JP2018140985A (en) Method for production of aromatic compound
CN103483283A (en) Synthesis method for antioxidant 1790
CN109678741A (en) The preparation method of 4- amino -3- fluobenzoic acid
CN114163385B (en) Method for promoting oxidation of tetrahydroisoquinoline compounds to lactam compounds by using surfactant
CN110922285B (en) Method for preparing aryl primary amide by metal catalysis one-pot method
CN107011218A (en) A kind of fluorine nitrogen type amination reagent, its preparation method and application
Pattarozzi et al. ‘Ligand-Free-Like’CuCl-Catalyzed Atom Transfer Radical Cyclization of N-Substituted N-Allyl Polychloroamides to γ-Lactams
CN112480112B (en) Method for synthesizing substituted dihydrophenanthroline compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant